Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$3.21M$3.21Mderived+41.0% vs Q4 2018 Net Income-$1.65M-$1.65MderivedN/M vs Q4 2018 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,418,154N/M Operating Cash Flowderived-$466,295N/M Free Cash Flowderived-$466,105N/M Margins · derivedOperating margin-44.2%−1.2 pt vs Q4 2018
Net margin-51.3%+2.2 pt vs Q4 2018
ended Dec 31, 2019 · filed Mar 27, 2020 · 87 d after period end